Form 8-K 8-21-06
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: July 29, 2006
(Date of earliest event report):


AMS HEALTH SCIENCES, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)


OKLAHOMA
001-13343
73-1323256
(State or Other Jurisdiction of Incorporation or Organization)
(Commission File Number)
(IRS Employer Identification Number)


711 NE 39th Street, Oklahoma City, OK 73105
(Address of Principal Executive Offices) (Zip Code)


Issuer’s telephone number, including area code: (405) 842-0131

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Information to be Included in the Report

Item 8.01. Other Events

On July 29, 2006, AMS Health Sciences, Inc. held its Annual Convention for its independent associates. Our Chairman, President and Chief Executive Officer, Jerry W. Grizzle provided closing comments at the convention to our independent associates that were in attendance outlining his plan for our future operations. A copy of the closing comments is attached hereto as exhibit 99.1.

Certain statements in the attached exhibit constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Certain, but not necessarily all, of such forward-looking statements can be identified by the use of forward-looking terminology such as “anticipates”, “believes”, “expects”, “may”, “will”, or “should” or other variations thereon, or by discussions of strategies that involve risks and uncertainties. Our actual results or industry results may be materially different from any future results expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include general economic and business conditions; our ability to implement our business and acquisition strategies; changes in the network marketing industry and changes in consumer preferences; competition; availability of key personnel; increasing operating costs; unsuccessful advertising and promotional efforts; changes in brand awareness; acceptance of new product offerings; changes in, or the failure to comply with, government regulations (especially food and drug laws and regulations); product liability matters; our ability to obtain financing for future acquisitions and other factors. We do not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.


Item 9.01. Financial Statements and Exhibits

(c) Exhibits

99.1  
Closing Comments from AMS Health Sciences, Inc. 2006 Annual Convention







SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

 
AMS HEALTH SCIENCES, INC.
   
 
/S/ ROBIN L. JACOB
 
      By: Robin L. Jacob
 Date: August 21, 2006
      Vice President and Chief Financial Officer





EXHIBIT INDEX


Exhibit No.
Description
Method of Filing
99.1
Closing Comments from AMS Health Sciences, Inc. 2006 Annual Convention
Filed herewith electronically